Schaer Pharma
Schaer Pharma has acquired the human OTC Pharma business of Dômes Pharma
Identification that the human OTC business of the French veterinary group Dômes Pharma was non-core and originating negotiations with Schaer Pharma who we advsided throughout the whole process. After a share deal collapsed in December 2017 an asset deal was closed in June 2018.
Dômes Pharma
Hoffmann & Partner
We support and professionally manage the M&A process from the first steps to the successful transaction. In doing our work we are accustomed to outmost discretion and swift execution. We help our clients making company value potentials visible and realizing them in transactions. Life sciences and high-tech transactions: We know how to sell (and acquire) technologies and we specialise in complex international transactions of technology companies. M&A in the regional service and industrial sectors of Switzerland: As the leading M&A firm in the Basel area, we are very experienced with company sales and acquisitions in the regional industries of Northwestern Switzerland and neighbouring economic regions. Many of these transactions are international.
+41 61 485 93 00
kurmann@juergkurmann.com
http://hoffmann-partner.com/en/
